Approved Study Database

Ref. No. Scientific Title Principal investigator
2006.357 Economic Impact of Subsituting Lamivudine with Entecavir in Chronic Hepatitis B Patients in the Public Health Care Sector of Hong Kong LEE KC Kenneth
2006.356 The Prevalence of Hearing Problems, and the Use of Self-Report Hearing Handicap Measures Against Pure-Tone Audiometry Results in Hong Kong Secondary School Children - A Pilot Study NG Hoi Yee Iris
2006.355 A Randomized 2-Arm, Open-Label, Phase II Study of BMS-582664, Administered Orally at A Dose of 800mg Daily or Doxorubicin Administered Intravenously At A Dose of 60 mg/m2 Every 3 Weeks In Patients with Unresectable, Locally Advanced or Metastatic Hepatocellular Carcinoma Prof. Yeo Winnie
2006.354 Psychosocial Impairment and Its Impact on Quality of Life on Harbouring an Untreated Unruptured Intracranial Aneurysm (PIH WONG KC George
2006.353 Accuracy Study on Common Point-of-Care Glucometer Models in Hong Kong CHAN Ho Ming Michael
2006.352 Fruit and Vegetable Intake among Hypertensive Subjects YIP Ka Yan Lily
2006.351 An Exploratory Study of the Satisfaction with Autipsychotic Medication of Patients with Schizophrenia in Hong Kong LIU Tai Wa
2006.350 Effectiveness of Immediate Controlled Active Motion (ICAM) Program Following Zone 4-7 Extensor Tendor Repair CHAN Pui Sze Caise (No email contact)
2006.349 Involvement in Medical Decisions, Received Information, Satisfaction with Care, Psychological Well Being and Unmet Health Care Needs in Patients with Psoriatic Arthritis as Compared with Patients with Rheumatoid Arthritis LEUNG Ying Ying
2006.348 RAISE (RAndomized placebo-controlled ITP Study with Eltrombopag): A Randomized, Double-Blind, Placebo-Controlled Phase III Study, to Evaluate the Efficacy, Safety and Tolerability of Eltrombopag Olamine (SB-497115-GR), A Thrombopoietin Receptor Agonist, Administered for 6 Months As Oral Tablets Once Daily in Adult Subjects with Previously Treated Chronic Idiopathic Thrombocytopenic Purpura (ITP) Prof. Cheng Gregory
2006.347 An Open-Label, Multicenter, Randomized Study of Combination Therapy with Oral Telbivudine Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-Positive Patients with Chronic Hepatitis B Who are Lamivudine Resistant Prof. Chan L.Y. Henry
2006.346 A Pilot Study to Investigate the Response of IMD-0354 Ointment in Patients with Atopic Dermatitis Prof. Hon Kam Lun Ellis
2006.345 A Pilot Study to Investigate the Efficacy and Safety of IMD-1041 in Patients With Type II Diabetes Mellitus Prof. Brian Tomlinson
2006.344 Is High Dietary Fiber Intake Beneficial in Treatment of Conostipation in Long-Term Care? A Randomized Controlled Trial TSANG Suet Mui (No email contact)
2006.343 The Effect of Functional Inserts with Different Posting Angles on Impact Force, Plantar Pressure Distribution and Foot Kinematics during Walking and Jogging CHAN Kai Ming
2006.342 A Preliminary Assessment of Safety and Antiviral Activity of Open-Label Entecavir in Subjects with Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials Dr. Leung W.Y. Nancy
2006.341 Avoiding Manual Removal of Placenta: Phase II Trial of Intra-Umbilical Injection of 1200mcg Misoprostol ROGERS MS
2006.340 Predictors of Survival in Patients with Unresectable Hepatocellular Carcinoma-Clinical, Quality of Life and Virological Factors Prof. YEO Winnie
2006.339 The Determination of the Prevalence of HIV and HCV Infection in Injection Drug users inLiuzhou, Guangxi, Mainland China LEE Shiu Shan
2006.338 A Multi-Center Phase III Randomized, Double-Blind Placebo-Controlled Study of the Cancer Vaccine Stimuvax_ (L-BLP25 or BLP25 liposome vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects with Unresectable Stage III Disease Prof. Mok S.K. Tony
2006.337 Reliability and Validity of the Chinese Stroke Adapted - Sickness Impact Profile 30-item (SA-SIP 30) in Hong Kong CHAN Yuk Lin Dora
2006.336 Routine Skin Moisturization for Atopic Dermatitis in Chinese Children- How Much Emollient do they use? HON Kam Lun Ellis
2006.335 A Single Centre, Open-Labeled Observational Study on the Efficacy of Benfotiamine in the Treatment of Painful Diabetic Neuropathy CHOW CC Francis
2006.334 Measurement of Patient Reported Outcomes in Renal Transplant Patients with and Without Gastrointestinal (GI) Symptoms (PROGIS) in Hong Kong YU WY Alex
2006.333 Compliance with Osteoporosis Medication Risedronate Prof. Leung Ping Chung
2006.332 A Pilot Study on Reduction in Fear of Falling Through Systematic Desensitization: Randomized Controlled Trial CHAN Yu Wai
2006.331 Surgical Outcome Analysis and Psychological Evaluation of Intersex Patients Managed Between 1993 and 1995 YEUNG CK
2006.330 Effect of Short-Term Corticosteroid on the Viral Kinetics of Hepatitis B Virus in Patients with Exacerbation of Chronic Obstructive Pulmonary Disease CHAN Lik Yuen Henry
2006.328 Validated Objective Measure of Actual Nursing Workforce in Relation to ICU Patient Outcome: A Cohort Study in Hong Kong CHEUNG Yip Sing Leo
2006.327 Exploring the Grief of Nurses after Patients Die in Adult Intensive Care Unit in Hong Kong YU Hoi Un
2006.326 Validation of Transient Elastography (Fibroscan) with Liver Histology and Morphometry for the Assessment of Liver Fibrosis Prof. Chan LY Henry
2006.325 A Cross-Sectional Study of the Effect of Acne on Quality of Life and the Role of Diet on Acne, from a TCM Perspective, among Hong Kong College Students LAW Pui Man Michelle
2006.324 Hepatocellular Carcinoma Research Group: Clinical Applications of Functional Genomics WONG Nathalie
2006.323 Galantamine for the Treatment of Probable Vascular Dementia or Possible Alzheimer Dr. Ho Wan Sze Wency
2006.322 Validation Study of Modified Rivermead Mobility Index and Modified Functional Ambulation Classification for Stroke Patients TSANG Chi Chung
2006.321 A Single Nucleotide Polymorphism (SNP) Based Method to Investigate the Origina of Circulating Albumin RNA LO Yuk Ming Dennis
2006.320 Isolation of the Patient-Specific Stem Cells from Neurosurgical Specimens POON Wai Sang
2006.319 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ -333369 as Adjunctive Therapy in Subjects with Partial Onset Seizures Followed by an Open-Label Extension Study Dr. Kwan Patrick
2006.318 Randomized, Double-Blind Trial Comparing the Effects of A 3-Month Clopidogrel Regimen, Combined with ASA during the First Month, Versus ASA Alone for the Acute Treatment of Patients with TIA or Minor Stroke CASTIA-Clopidogrel in Acute Stroke and TIA Dr. Leung Wai Hong Thomas
2006.317 A Phase 2, 12-Week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of A Range of SCH 420814 Doses (1mg BID, 2mg BID, 5mg BID, and Possibly 10mg BID) in Subjects with Moderate to Severe Parkinson Dr. Mok C.T. Vincent
2006.316 Quality Evaluation of Stroke Care and Treatment (QUEST) - ChinaQUEST is a Prospective, Multi-cCentre, National Study in Representative Urban, Suburb, and Rural Regions to Assess Stroke Management, Secondary Preventio, and Outcomes in China WONG KS Lawrence
2006.315 Pharmacogenetics of Fluoxetine in Chinese Patients (Protocol No. RES-06-01) CHOW Sing Sum Moses
2006.314 Bioequivalence Studies on Hydroxychloroquine (BABE-O06-040) CHOW Sing Sum Moses
2006.313 A Proteomic Study of the Cardiovascular Systems of Chinese Subjects KWAN Yiu Wa
2006.312 A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects with Type 2 Diabetes Mellitus Prof. Ko Tin Choi Gary
2006.311 GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets Prof. Clive Stewart Cockram
2006.310 Phase 2 Study of SU011248 in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Prof. Chan T.C. Anthony
2006.309 Early Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis (ESASIS) Dr. LEUNG Thomas Wai Hong
2006.308 A Randomized Controlled Trial of Identifying Predictors of Poor Bowel Preparation in the Elderly (BP Study) Prof. Lee Yuk Tong
2006.307 Open Label Study of bevacizumab (AVASTIN_) in Combination with Platinum Containing Chemotherapy as First Line Treatment of Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer (SAIL-Safety of Avastin In Lung) Prof. Mok Tony

Page 223 of 254.